Roy S. Weiner, M.D.
Associate Dean for Clinical Research and Training
Associate Director of Clinical Research for Tulane Cancer Center
Professor of Medicine, Pediatrics, and Epidemiology
Edward G. Schlieder Educational Foundation Chair in Medical Oncology
TCC Program Member
(504) 988-6061, (504) 988-6949 fax
1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699
Dr. Weiner obtained his M.D from SUNY at Brooklyn (1967). He trained in internal medicine at Johns Hopkins Hospital and at the Hospitals of the University of California in San Francisco. After fellowships at the N.I.H. and l’Institut de Cancerologie et d’Immunogenetique in Villejuif, France, he joined the teaching faculty at Harvard Medical School and was research associate then assistant professor at the Dana Farber Cancer Institute and the Brigham and Women’s Hospital. In 1976, he became associate professor and chief, Division of Medical Oncology, at the University of Florida. He held the American Cancer Society Professorship there until 1993. Dr. Weiner moved to Tulane University in 1993 as the Schlieder Chair and founding director of the Tulane Cancer Center. In 2002, he assumed a second role as founding co-director of the Louisiana Cancer Research Consortium (LCRC). On July 1, 2007, Dr. Weiner was named Tulane University School of Medicine’s associate dean for clinical research and training. In his new position, Dr. Weiner works with center directors and department chairs to enrich Tulane University’s clinical research environment. He also oversees the Master of Science in Clinical Research (MS-CR) program, designed to prepare the next generation of clinical and translational researchers and to transform Louisiana into a destination for clinical research for both patients and the pharmaceutical industry. Through a P-20 Planning Grant funded by the National Cancer Institute, he is leading an effort to form a Center with Xavier University concentrating on cancer outcome disparities based on race and ethnicity. He is also working with faculty at both Tulane and Xavier to formally incorporate cultural competence into the curriculum of medical (Tulane) and pharmacy (Xavier) students. In addition to his academic responsibilities, Dr. Weiner remains an active cancer clinician and associate director of the LCRC for clinical cancer research.
Dr. Weiner's basic research contributions are focused on human hematopoeitic stem cell physiology, cell separation and stem cell cryopreservation. The methods he developed for freezing and thawing human mononuclear cells are used widely today in basic research and in clinical stem cell transplantation. His clinical research contributed to the modern multi-drug treatment of adult leukemia and, more recently, the multimodality therapy of locally advanced breast cancer. He has published more than 140 scientific papers in peer-reviewed journals, many invited papers, and has edited several books. He is on the editorial boards of several scholarly journals and has served the AACR, ASCO, and ASH in leadership positions.
- Miller AM, Conley NS, Allen B, Hoover DL, Weiner RS. (1994) Bleomycin-induced differentiation of a human monoblast cell line U937. Cancer Res Ther and Cont 4 (2): 149-153.
- Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig HA, Keating A, Klein JP, Marmont AM, Prentice G, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM. (1996) HLA-identical sibling bone marrow transplants versus chemotherapy for acute myeloid leukemia in first remission. Leukemia 10(11): 1687-91.
- Kao KJ, Noyes W, Weiner RS, Hudson S, Waldman-Slone A. (1997) Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions. NEJM 337(26): 1861-1869.
- Champlin RE, Passweg JR, Zhang MJ, Rowling PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringden O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM. (2000) T cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 95(12): 3996-4003.
- Miller AM, Morrison D, Safah H, Cullins S, LaRussa V, Rink J, Weiner RS. (2000) Decreased Quality of Peripheral Blood Progenitors Collected after a Peripheral Blood Progenitor Transplant. J Hemat Stem Cell Res 9: 475-480.
- Bennett CL, Stinson RJ, Vogel V, Robertson L, Leedy DL, O'Brien P, Hobbs J, Sutton T, Ruckdeschel T, Chrirkos T, Weiner RS, Ramsey M, Wicha M. (2000) Evaluating the financial impact of clinical trials in oncology: results from a pilot sutdy from the Association of American Cancer Institutes/Northwestern Univeristy clinical trials costs and charges project. J Clin Onc 18(15): 2805-2810.